Analyse des Interfaces de complexes Anticorps - Antigène:  des caractéristiques propres au type de ligand à la prédiction d'affinité de liaison by Marillet, Simon et al.
HAL Id: hal-01191462
https://hal.inria.fr/hal-01191462
Submitted on 1 Sep 2015
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Dissecting Interfaces of Antibody -Antigen Complexes:
from Ligand Specific Features to Binding Affinity
Predictions
Simon Marillet, Marie-Paule Lefranc, Pierre Boudinot, Frédéric Cazals
To cite this version:
Simon Marillet, Marie-Paule Lefranc, Pierre Boudinot, Frédéric Cazals. Dissecting Interfaces of Anti-
body -Antigen Complexes: from Ligand Specific Features to Binding Affinity Predictions. [Research









































SOPHIA ANTIPOLIS – MÉDITERRANÉE
2004 route des Lucioles - BP 93
06902 Sophia Antipolis Cedex
Dissecting Interfaces of Antibody - Antigen
Complexes:
from Ligand Specific Features to Binding
Affinity Predictions
Simon Marillet∗ and Marie-Paule Lefranc† and Pierre
Boudinot‡ and Frédéric Cazals §
Project-Team Algorithms-Biology-Structure
Research Report n° 8770 — September 2015 — 58 pages
Abstract: Adaptive immunity is based on antigen-specific lymphocyte responses, with in
particular B cells secreting seric immunoglobulins (IG) involved in the opsonization of bacteria
and the neutralization of viruses. At the heart of these mechanisms is the formation of IG -
Ag complexes, which challenge our understanding in terms of binding affinity and interaction
specificity.
In this work, we dissect the interfaces of IG - Ag complexes with high resolution crystal structures,
making a stride towards a better understanding of binding affinity and interaction specificity. First,
we present global interface statistics clearly distinguishing ligand types (proteins, peptides, chem-
ical compounds), and stressing the role of side chains. Second, we analyze the relative positions of
CDR with and without antigen, exhibiting a remarkably conserved pattern involving seven seams
between CDR. We also show that this generic pattern exhibits specific properties as a function of
the ligand type. Finally, we present binding affinity predictions of unprecedented accuracy, with a
median absolute error of 1.02 kcal/mol.
We anticipate that our findings will be of broad interest, not only in studying immune responses
at the structural level, but also in bio-engineering and IG design, with IG used extensively in
diagnostics and as well as therapeutic agents.
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Analyse des Interfaces de complexes Anticorps - Antigène:
des caractéristiques propres au type de ligand à la
prédiction d’affinité de liaison
Résumé : L’immunité adaptative est basée sur une réponse lymphocytaire spécifique de
l’antigène, les lymphocytes B sécrétant en particulier des immunoglobulines (IG) sériques im-
pliquées dans l’opsonisation des bactéries et la neutralisation des virus. Au cœur de ces mé-
canismes se situe la formation de complexes IG - Ag, défiant notre compréhension quant à la
prédiction de l’affinité de liaison et de la spécificité des interactions.
Dans ce travail, nous disséquons les interfaces de complexes IG - Ag à partir de structures
cristallographiques à haute résolution, faisant ainsi un pas en direction d’une meilleure com-
préhension de l’affinité de liaison et de la spécificité des interactions. Premièrement, nous présen-
tons des statistiques sur les interfaces dans leur globalité permettant de distinguer clairement
les types de ligands et de souligner l’importance des chaines latérales. Deuxièmement, nous
analysons les positions relatives des CDR en contact ou non avec un antigène, exhibant ainsi
un motif remarquablement conservé impliquant sept coutures entre les six CDR. Nous montrons
également que ce motif générique possède des propriétés spécifiques au type de ligand. En-
fin, nous présentons des prédictions d’affinité d’une précision inégalée, avec une erreur absolue
médiane de 1.02 kcal/mol.
Ces résultats sont d’intérêt général, non seulement pour l’étude des réponses immunitaires
au niveau structural, mais également pour l’ingénierie biologique et le design d’IG, celles-ci étant
largement utilisées pour les diagnostics et en tant qu’agents thérapeutiques.
Mots-clés : Complexe anticorps - antigène ; interface ; affinité; positions relatives des CDR
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1 Introduction
1.1 Immunoglobulins and the immune response
Adaptive immunity is based on antigen (Ag)-specific lymphocyte responses. Upon specific recog-
nition of an antigenic epitope by a given receptor unique to a lymphocyte, this cell gets activated
and proliferates, leading to a clonal expansion. B lymphocytes thus recognizes the native antigen
through immunoglobulins (IG) or antibodies on their membranes. Following differentiation of
lymphocytes into plasmocytes, IG are then secreted and bind the antigen as a soluble receptor.
Seric IG can opsonize bacteria and facilitate their uptake by phagocytes, or neutralize viruses
thus preventing recognition by their receptor or fusion with the target cell. During the secondary
immune response, affinity maturation is responsible for the secretion of IG of higher affinity, a
gain of up to three orders of magnitude being common.
Immunoglobulins fundamentally consist of two identical heavy (H) chains and two identical
light (L) chains, each H chain being bound to an L chain by a disulfide bond and by noncovalent
interactions between the variable domains VH and VL and the constant domains CH1 and
CL. The antigen-binding site is located at the top of the paired VH and VL, and generally
overlaps the two V domains. It mainly consists of three flexible loops on each V domain, called
complementarity determining regions (CDR1-3) [72, 9].
Matching the universe of antigenic motifs specifically requires a very large diversity of recog-
nition modes by immunoglobulins. This is achieved by a huge diversity of the loops constituting
the antigen binding sites at the top of the VH and VL domains. The aforementioned CDR1 and
2 are encoded by the V gene and their diversity depends on genes and alleles, whereas the CDR3
loop corresponds to the site of the V(D)J rearrangements, which generate the highest sequence
diversity [68], [55, Chapter 6].
1.2 IG - Ag complexes under the structural lens
From the structural standpoint, the functional relevance of an IG is described by its binding
affinity for the targeted antigen and the specificity of such interactions. The specificity is critical
to ensure that the response targets the antigen, and not, for example, a motif present on a self
protein - and it is also the basis of immune memory and vaccination. The affinity sets the strength
of the interaction and the time the antigen and the antibody are linked to each other. For the
membrane bound IG, it determines if enough aggregation of surface IG and IG co-receptors
occurs, so that a sufficient signal can be sent to the cell to induce activation and proliferation;
for secreted IG, it sets the efficiency of IG-mediated pathogen opsonisation and/or neutralization,
or IG effector properties (antibody-dependent cell-cytotoxicity (ADCC), complement-dependent
cytotoxicity (CDC)), after binding to the target infected or tumoral cells [42]. In mouse and
human, secondary immune responses are often accompanied by affinity maturation, a process
during which B cells expressing IG with enhanced affinity are being selected. Such IG with
higher affinity result from the selection of random mutations of their V(D)J genes produced
by the enzyme activation-induced cytidine deaminase (AICDA, AID), which may modify the
structure of the antigen binding site, hence the affinity of the interaction with the Ag.
The binding affinity is a thermodynamic parameter describing an equilibrium between three
species, namely the partners and the complex they form. It is generally measured by a dis-
sociation constant Kd of this equilibrium, or equivalently by the associated dissociation free
energy. Thus, by nature, the affinity has enthalpic and entropic components. The enthalpic
component describes the interaction energy. Generically, given two partners forming a complex,
various parameters have been proposed to model the complex. Most of these parameters tar-
get the interface, and describe its size and morphology, shape (number of patches), biochemical
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properties (salt bridges, solvation, H bonds), or packing properties and have been studied using
crystal structures of complexes, see [33, 46, 8, 48] and the references therein. More recently, it
has also been shown that non-interacting atoms play an important role, intuitively related to
solvent interactions [35]. For the particular case of IG - Ag complexes, it has been observed
that interfaces tend to have a smaller size, have curvature dependent on the ligand size [47].
The entropic component accounts for the dynamics of the partners. In particular, it has been
shown that preconfiguration/prerigidification of the binding site may yield a decreased entropic
loss, hence a enhanced binding affinity [49, 59, 15, 60]. The specific role played in Ag binding
by CDR also prompted the analysis of CDR specific statistics. Using a handful of structures,
canonical structures i.e. commonly occurring backbone CDR conformations were first reported
[17] and subsequently updated [18, 2]. Moving from individual CDR to all CDR, correlations
between canonical structures were further studied [70], highlighting the fact that selected com-
binations are multi-specific, while others are specific of an antigen type. The VH CDR3 is the
most variable and was therefore the focus of several studies [62, 53, 64] which defined and up-
dated sequence-based rules to predict its conformations. More recently, these studies have been
refined, based on a larger number of structures (of the order of hundreds instead of tens). For
VL CDR3, new canonical structures were proposed [38], and for VH CDR3, previous rules were
updated and complemented [36, 37]. The work of Chothia et al [17] was also refined using 300
nonredundant IG structures and a pre-processing based on CDR length [54]. Distinguishing
lambda versus kappa chains, it has been shown that canonical conformations from the former
are more diverse than those from the latter in the human and the mouse [13]. However, the
use of canonical conformations was questioned [16], since general prediction methods for loops
matched (or even outperformed) the prediction performances of methods exploiting specific rules
associated with canonical structures of CDR. Finally, two related works [3, 58] studied the dif-
ferential CDR lengths and SDRU (proportion of structures contacting the antigen at a given
site) between ligand types. However, these analysis do not extend to predictions of the antigen
type. More generally, the reader may consult [27] for a review of structural and genetic aspects
of natural and artificial antibody repertoires.
While the previous analyses certainly shed light on antigen recognition modes, they fall
short from providing complete information on binding affinity. Predicting binding affinities from
structural data is a notoriously challenging problem, for protein complexes in general [34, 50],
and for IG - Ag complexes in particular [45]. This actually owes to the intrinsic nature of
Kd, namely a macroscopic property describing the chemical equilibrium associated with the two
partners (IG and Ag) and the complex (IG - Ag, denoted IG/Ag in the IMGT nomenclature
[25]). That is, the magnitude of Kd has an enthalpic component, qualifying the strength of the
interaction, but also an entropic component qualifying the loss of dynamical properties upon
complex formation – intuitively the formation of the IG - Ag complex restricts the degrees
of freedom of both partners. These two competing interests illustrate the enthalpy - entropy
compensation phenomenon [52, 24], which stipulates that a favorable enthalpic change upon
association is accompanied by an entropic penalty. In [56] and [69] the authors have shown that
a preconfiguration process of the variable domains can be induced by the constant domain 1
(CH1) of the heavy chain, suggesting that the isotype switching commonly occurring during B
cell differentiation may affect the affinity through changes in the dynamic properties of the IG.
Parallel to binding affinity, the notion of functional affinity or avidity which takes into account the
(possibly negative) cooperativity between IG is highly relevant in-vivo. In that context, constant
regions have been shown to influence the avidity [22, 23, 51, 57]. Likewise, am intact ball-and-
socket joint between VH and CH1 domains has been shown to condition antibody neutralizing
activity [39].
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Contributions. This work sheds new light on IG - Ag interactions. We use the annotated
IMGT/3Dstructure-DB [25], focusing on canonical complexes, each such complex involving ex-
actly one variable domain from the heavy chain (VH), one variable domain from the light chain
(VL) and one antigen (Ag). Of particular interest is the ligand type (reduced to protein, pep-
tide and chemical in this paper, see Section 2.3). Upon extracting canonical complexes from the
IMGT/3Dstructure-DB, our analysis relies on hierarchical Voronoi interface models, and involves
three main steps. IG atoms are first marked as belonging to CDR or framework regions (FR),
using the IMGT unique numbering [43]. (Practically, we use the following notations: CDR1-
IMGT of VH is written VH CDR1 and FR3-IMGT of VL is written VL FR3. Other CDR and
FR follow the same scheme.) Subsequently, the interface between the IG chains and the Ag is
determined using a Voronoi based model, and hierarchically decomposed into contributions from
CDR, FR and other atoms.
Using these tools, we present novel analysis for IG - Ag complexes, in three directions. First,
we report global interface statistics, in particular as a function of the ligand type, stressing the role
of side chains and going beyond previous work solely based on backbone canonical conformations.
In particular, these statistics discriminate between different ligand types, a key observation to
understand binding specificity. Second, we present novel analysis of the relative contributions of
CDR to binding, highlighting the relative positions of CDR. We notably mitigate the classical
view of prominent contribution of CDR3 to the interface, showing that in terms of buried surface
area, CDR3 on the one hand, and CDR1 + CDR2 on the other hand, must be considered on an
equal footing. We also show that there exist a conserved pattern of contacts between CDR, with
specific properties depending on the antigen type. Finally, we present binding affinity predictions
of unprecedented accuracy.
2 Material and Methods
2.1 Voronoi Interface Models
Given a macro-molecular complex, an interface model is a structural model of the atoms account-
ing for the interactions. Various interface models have been developed, based in particular on
distance thresholds and loss of solvent accessibility [4]. In the sequel, we use the Voronoi based
interface model, which is a parameter free construction improving on previous models in several
aspects. Since we shall be using features of this model, we present it briefly. (See also Fig. 1 for
an illustration on an IG - Ag complex.)
Solvent accessible models. The solvent accessible model (SAM) of a set of atoms is a model
where each atom is represented by a ball whose radius is the van der Waals radius expanded
by the radius rw = 1.4Å of a water probe accounting for a continuous solvation layer [28, 4].
A convenient construction to study SAM is the Voronoi (power) diagram defined by the atoms
[28]. In particular, the Voronoi diagram induces a partition of the molecular volume, obtained by
computing for each atom its Voronoi restriction, namely the intersection between its atomic ball
and its Voronoi region. The volume of a restriction can be used to define packing properties: the
raw packing property of one atom is plainly the volume of its restriction; the normalized packing
property is the volume of the restriction normalized by the volume of the corresponding ball.
Buried surface area. The exposed surface of a SAM consists of the boundary of the union of
balls defining the SAM. (Prosaically, the visible surface of the molecule.) This surface consists of
spherical polygons, delimited by circle arcs (every such arc is located on the intersection circle of
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two atoms), themselves delimited by points (each such point is found at the intersection of three
spheres). When two molecules assemble to form a complex, the buried surface area (BSA) is the
portion of the exposed surface of the partners which gets buried [46]. BSA has been shown to
exhibit remarkable correlations with various biophysical quantities [32], and notably dissociation
free energies for complexes involving moderate flexibility [48].
Voronoi interface. Consider the SAM of a complex whose partners are denoted A and B, and
also involving water molecules tagged W. Two atoms are in contact provided that their Voronoi
restrictions are neighbors. Pairs of type (A,B) define the AB interface, namely direct contacts
between the partners. Focusing on W molecules sandwiched between the partners, pairs (A,W)
and (B,W) correspond to water mediated interactions. It can be shown that all atoms from
the partners identified this way form a superset of atoms loosing solvent accessibility [12]. The
binding patch of a partner consists of its interface atoms. The atoms of the binding patch can
be assigned an integer called its shelling order, which is a measure of the distance of this atom
to the boundary of the patch it belongs to [8]. This information generalizes the core-rim model
[46], and has been shown to provide STAR correlations with solvent dynamics, conservation of
amino acids [8], and dissociation free energies [48].
The Voronoi facets associated to pairs of type (A,B) define the bicolor interface A − B
(bicolor since there are two partners); those associated to pairs of type (A,W ) and (B,W ) define
the mediated interface AW − BW , since interactions between A and B are mediated by W
molecules; finally, the union of the bicolor and mediated interface define the tricolor interface
ABW . Geometrically, this interface is a polyhedron separating the partners. The curvature of
this polyhedron is easily computed [11], and has been shown to provide information on binding
modes [12].
Application to IG - Ag complexes. We partition the set I of interface atoms into the atoms
IIG contributed by the IG, and the atoms IAg contributed by the Ag, so that I = IIG ∪ IAg. It
follows that the number of interface atoms |I| satisfies |I| = |IIG|+ |IAg|. Similarly, we charge
the Buried Surface Area BSA to the IG and Ag respectively, so that BSA = BSAIG + BSAAg.









Note that the previous average surface areas are computed using interface atoms only–not the
number of atoms or exposed atoms of the whole individual molecules.
2.2 Hierarchical Voronoi Interface Models
Consider a complex where partner A is an IG, and partner B an antigen. We wish to accom-
modate the hierarchical structure of a Fab [42]. We focus on the variable domains of the heavy
and light chains, denoted VH and VL respectively, and decompose each of them into seven
regions, namely three Complementarity Determining Regions (CDR), and the four Framework
Regions (FR) flanking them [43] (Supp. Table 1). For example, the domain VH is decomposed
as FR1+CDR1+FR2+CDR2+FR3+CDR3+FR4.
Consider the partition of he variable domains VH and VL induced by the previous 14 labels.
For the sake of conciseness and since we focus on interfaces involving the variable domains only,
Inria
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the domains VH and VL are plainly denoted H and L. Using these notations, we partition the
IGAg interface as follows:
• Hierarchical bicolor interface: IGAg = (L ∪H)Ag = V LAg ∪ V HAg
• Hierarchical mediated interface: IGW −AgW = (LW −AgW ) ∪ (HW −AgW )
• Hierarchical tricolor interface: IGAgW = IGAg ∪ (IGW −AgW )
Analogously, the partition of the H (or L) V-domain into seven CDR and FR regions induces a
partition of the HAg (or LAg) interface (Fig. 2).
2.3 The Dataset and Data Curation: the IMGT/3Dstructure-DB
Structure From a structural standpoint, we use the IG - Ag complexes from the IMGT/3Dstructure-
DB (http://www.imgt.org/3Dstructure-DB/ [25]), corresponding to the category IG/Ag for
IMGT complex type. Only PDB files are kept. This dataset featured 1363 complexes as of Jan-
uary 2015. Of these complexes, 30 had been removed from the database by May 2015. We also
discarded four files: two which contain only an IG and buffer molecules with no ligand (1MJU
and 4KQ3), and two which contain an IG in complex with a molecule specifically crafted to bind
the middle part of the IG (4GW1 and 4IOI). Each such complex is processed in order to identify
canonical complexes (Supp. Section 7.1),
Upon inspecting these cases, two decisions are made. First, on the antigen side, we retain
three types only (peptide, protein, chemical), due to the scarcity of cases involving other types
(See also Supp. Fig. 11 for the distribution of ligands’ sizes.) Moreover, we also remove complexes
involving multiple ligands types. For the same reason, regarding species, complexes are assigned
to three classes human, mouse and other. A total of 529 complexes are retained after filtering
for missing data, inconsistencies and redundancy (Supp. Table 2). CDR and FR limits of the
VH and VL domains [41] are according to the IMGT unique numbering [43] (Supp. Table 1).
3 Results
3.1 Global interface analysis
Signatures of binding patches exhibit a broken symmetry between the IG and Ag
side. The simplest and most informative variable describing protein interfaces is the buried
surface area (BSA) [32], a statistic known to strongly correlate with the number of interface
atoms |I| (on our dataset: Pearson coefficient of 0.99, p-value < 2.225−308; see Supp. Fig. 13a).
When considering the average BSA per atom for the IG and the Ag (Eqs. 1 and 2 respectively),
weaker correlations are observed, since the Pearson coefficient drop to 0.83 for |IIG| and BSAIG
(p-value = 5.176e−136, Supp Fig. 13b), and to 0.90 for |IAg| and BSAAg (p-value = 2.161e−189,
Supp Fig. 13c). This is due to the shape complementarity between the interfaces on the IG
and Ag size, causing the sum of the BSAs and the number of atoms on each side to balance
out. Prosaically, for small ligands, the binding patch of the IG wraps around that of the Ag.
This fact is also supported by the negative correlation between bsaIG and bsaAg (Fig. 3), with
Pearson’s coefficient of -0.84 (p-value = 1.032e−143), and Spearman coefficient of -0.90 (p-value
= 2.257e−188).
Strikingly, the ligand type has a strong influence on these quantities: complexes involving a
chemical ligand have a higher bsaAg than those involving a peptide ligand which in turn have
a higher bsaAg than those involving a protein ligand. Since chemical ligands are typically small
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and protein ligands are usually large (Supp. Fig. 11), we checked the correlation between ligand
size, bsaAg and bsaIG. Colors in the inset of Fig. 3 display the Ag size (number of atoms)
instead of its type: although the gradient suggests an influence of the ligand size, there is a mix
between large and medium-sized ligands in the right part of the plot. The circled outlier in Fig. 3
corresponds to entry 2O5X. It is a chimeric IG (gamma1-kappa Fab) in complex with a molecule
of TRIS buffer. Since buffer molecules are usually not bound by IG, this is likely the result of a
mis-labeling of such a molecule as ligand. Therefore unusual values of bsaAg and bsaIG can help
detecting issues in the dataset by checking blatant outliers.
Summarizing, the average BSA per atom is not symmetrical with respect to the IG and Ag
side of the interface because of the shape complementarity of the two binding patches. This lack
of symmetry depends itself on the type of ligand.
Signatures of binding patches also identify ligand types. The remarkable correlation
between the average BSA per atom on the IG and Ag sides provides a strong indication of the
ability of the two parameters bsaAg and bsaIG to characterize interfaces as a function of the
ligand type (Fig. 3). To further check this hypothesis, we build a decision tree to hierarchically
partition the two-dimensional space defined by bsaAg and bsaIG (Fig. 3, with the boundaries
of the partition displayed as black lines, and Supp. Fig. 14). (Practically, we used the R
package rpart with 10-fold cross validation, choosing the number of splits which minimize the
cross validation error, and further pruning the tree.) With a classification error of 0.077 (Supp.
Table 7), the regions defined by ligand types in the 2D parameter space indeed unambiguously
determine the ligand type (Fig. 3).
In short, the average BSA per atom bsaIG and bsaAg provide a proxy for the curvature of
binding patches on the IG and Ag sides, clearly discriminating between ligand types.
Side chain atoms: proportion at interface. A classical focus while analyzing IG - Ag
interface has been the study of backbone conformations [18, 13]. To assess the role of side chains,
we study the proportion of interface atoms belonging to a side chain (Supp. Fig. 15). Despite
some variability, the median is always between 0.68 and 0.72 across categories. Additionally,
there is no significant difference between species, ligand types or lambda/kappa IG.
The contacts made by atoms belonging to the backbone are therefore far from being negligible
but are still outnumbered by side-chain atoms.
3.2 On the respective contacts of CDR with the antigen
We now leverage interface statistics, exploiting the decomposition of the binding patches induced
by the CDR and FR regions (Fig. 2). Since CDR are essentially the only regions contacting the
antigen (Supp. Table 6), we focus on these six regions in the sequel.
On the lengths of CDR. As IG diversity of complete repertoires or in responses to specific
pathogens has been largely been studied by CDR3 length spectratyping [1, 10, 65], we analyze
the relationship between CDR length and recognition mode, and extend our survey to CDR1
and CDR2. From the analysis of the length of the various CDR in our dataset (Supp. Section
6.2, Supp. Fig. 16), four important points stand out.
First, for VL, a reduced set of CDR length combinations accounts for more than a third of the
dataset. Namely, a single combination of VL CDR1, VL CDR2 and VL CDR3 [6.3.9] accounts
for 35% of the human IG, and five combinations account for 65%. Moreover, two combinations
account for 54% of the murine IG. Such a coupling with CDR3 length does not occur in VH which
is likely related to the differences in the rearrangement process between VL and VH. Namely,
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VL CDR3 results from the recombination of only two genes, VL and JL, which reduces both
combinatorial and junctional diversity. Additionally, the DNA nucleotidylexotransferase (DNTT)
activity responsible of the nucleotide trimming and addition at the junction, is notoriously very
low when VL V-J rearrangements occur. Altogether, this leads to shorter junctions in VL
compared to VH. Second, our results confirm that VH CDR3 is the main region of diversity in
terms of CDR length which underlines the power of the CDR3 length spectratyping approaches
for repertoire characterization. Indeed, for the human dataset, apart from a peak at 12 amino-
acids (AA) (15% of the dataset), the lengths of 94% of VH CDR3 are evenly distributed between
10 and 22 AA. The situation is similar for murine IG with a peak at 12 AA (19% of the dataset) as
well, and 71% of VH CDR3 spread between 11 and 15 AA. On the other hand, both VH CDR1
and VH CDR2 are made of 8 AA for 81% of the human dataset, and for 66% of the murine
dataset. Third, VL CDR2 is always of length 3 in the human, and has length 7 in only two
murine IG. It is the least variable of all CDR and the shortest one on average. Finally, VL CDR1
length is more variable than that of VL CDR3 in the mouse. Indeed, VL CDR1 has 6 and 11
AA in 38% and 22% of the murine dataset, respectively, whereas 86% of murine IG have a VL
CDR3 of length 9, which is due to the well known lack of DNTT activity at the time of VL V-J
rearrangements.
BSA: contribution of VH versus VL. In an IG - Ag complex, it is generally believed that
VH contributes more to the recognition than VL. With a BSA of VH strictly larger than that
of VL for 457/529 complexes (86%) (Fig. 4), our analysis supports this claim. Among those
72 complexes for which the BSA of VL is larger than that of VH, the proportions of chemical,
peptide and protein ligands are 22%, 32%, 46%, respectively–to be compared to those of the
whole dataset: 15%, 24%, 62%, respectively. This is hardly conclusive, considering the small
number of such complexes. The analysis of outliers bears some interest (circled cases, Fig. 4).
The case 4OGY consists of a human IG (gamma1-kappa Fab) in complex with a protein (plasma
kallikrein). The ligand, is strongly shifted toward VH. Moreover, VH CDR1 and VH CDR3
protrude from the Fab and extensively contacts the ligand. As for 3NGB, it results from a
spurious assignment of Ag chains to the IG. Because four identical biological units are in the file
and the IMGT annotation puts all four ligand chains as a single ligand, a part of the interface
with VH actually comes from crystal contacts. This example shows that annotations issues can
be detected by checking blatant outliers.
BSA: contributions of the CDR within a V-domain. To refine the previous analysis, we
use our hierarchical interface models and dissect the BSA into contributions by the CDR within
a V-domain. This analysis shows a great deal of variation independent from the species or the
ligand type (Figs. 5). A common observation is that the sum of contributions of CDR1 and
CDR2 essentially matches that of CDR3 for both VH and VL. Namely, for 244/529 complexes
(46%) BSA(VH CDR1) + BSA(VH CDR2) > BSA(VH CDR3). This is less obvious for VL
since BSA(VL CDR1) + BSA(VL CDR2) > BSA(VL CDR3) for 218/529 complexes (41%). A
Wilcoxon signed-rank test does not find a significant difference between the BSA of VH CDR1
+ VH CDR2 and VH CDR3 (two-sided p-value = 0.1821), but does for VL CDR1 + VL CDR2
and VL CDR3 (two-sided p-value = 0.0004,) which confirms the previous results.
In the sequel, we call free CDR a CDR which does not loose any solvent accessibility–none
of its atoms is buried by an atom of the antigen. Complexes with free VH CDR1 or VH CDR2
are not uncommon since they occur for 48/529 (9%) and 53/529 (10%)) complexes, respectively
(Fig. 5a). This is much rarer for VH CDR3 (7/529 occurrences, 1%).
On the other hand, 255/529 (48%) complexes involve a free VL CDR2 (Fig. 5b), a fact to
be interpreted in the context of a lesser length variability and, as we shall see, a location on the
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side. 74/529 (14%) complexes have an free VL CDR1 and 39/529 (7%) complexes have an free
VL CDR3 which is almost seven times as much as VH CDR3.
In short, CDR1 and CDR2 contribute essentially as much as CDR3 in terms of BSA. Addi-
tionally, VH CDR3 is almost always at interface, whereas it is only the case for VL CDR2 in
half of the dataset. Finally, VL CDR tend to be away from interface more often than VH CDR.
CDR: lengths versus BSA. It has been observed that CDR length differ between different
antigen types [21, 58], a finding suggesting that CDR length influences the binding site shape to
accommodate the ligand. Since all the atoms of a CDR may not contribute to the interface, we
investigated the correlation between the length of a CDR and its contribution to the BSA (Figs. 6
and 7). Because of their shared genomic origin, we group CDR1 and CDR2 and subsequently
investigate the relationship between (CDR1, CDR2) pairs and BSA on the one hand, and CDR3
and BSA on the other hand.
As illustrated by the scatter plots, a CDR of a given length can display widely varying levels
of BSA. These results confirm that CDR lengths must be complemented to fully describe the
involvement of a CDR in the interaction with he Ag. This is backed up up by the very limited
ability of neural networks trained on sequence data only to predict the ligand type bound by an
IG in [21].
3.3 On the relative positions of CDR
The relative position of CDR is instrumental to understand binding modes, and has already been
described qualitatively (e.g., [21, Fig. 1]). To make such description quantitative (Figs. 8 and
9), we study the seams i.e. the contact curves between the six CDR. Since six CDR yield a total
of 15 pairs, our goal is to understand which pairs are in close vicinity. To this end, we consider
seams associated with all types of ligands, which, abusing terminology, we call consensus seams,
as well as seams observed for specific types of ligand.
More formally, recall that the boundary of a surface accessible model (SAM, see Section 2.1)
consists of spherical polygons, circle arcs, and points. For a given CDR, two sets of atoms are of
particular interest, namely the atoms making up the boundary of the SAM and the subset of these
atoms which are found at the interface with the ligand. We note in passing that median values
of the ratios between these two sets are 19%, 23%, 25%, for VH CDR1, VH CDR2, VH CDR3,
respectively, and 18%, 10% and 24% for VL CDR1, VL CDR2 and VL CDR3, respectively.
Consider two CDR, and one set of atoms per CDR (either exposed atoms, or interfacial ex-
posed atoms). The seam between these two sets of atoms is the contiguous set of circle arcs
separating these two sets of atoms, if any. Its length is defined as the cumulative length of
its constitutive circle arcs (Fig. 8). Practically, the seams associated with exposed and interfa-
cial exposed atoms yield complementary pieces of information: the former describe the relative
positions of CDR; the latter provide information on the ligand position across these seams.
We computed the length of seams observed between all pairs of CDR on groups of complexes
involving (i) the same ligand type, namely protein, peptide or chemical, and (ii) the same type
of VL domain, namely V-kappa or V-lambda. Denoting x and y two seam lengths, we define the
maximum normalized difference as the following number ∈ [−100, 100]:
MND(x, y) = 100 · x− y
max(x, y)
. (3)
Given two CDR, we use the MND to compare the median value observed on a class of IG - Ag
complexes, against the median value observed over all complexes – this latter value being referred
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to as the consensus value or the value of the consensus seam. It is negative when the class-specific
value is smaller than the consensus value, positive when it is greater and null if they are equal.
Consensus seams. We observe that the existing inter-chain contacts are the same when con-
sidering either all atoms or interface atoms only (Fig. 9, supp. Figs. 19 and 20). Intuitively, the
Ag spreads evenly on the surface of the IG, covering all the seams.
Considering intra-chain contacts, we notice that the same are found in the VH and VL
domains, namely CDR1 – CDR2 and CDR1 – CDR3. However, considering all atoms, these
seams are slightly longer in VH with respectively 24.6 Å and 30.9 Å versus 16.0 Å and 26.9 Å
for VL. The same applies for interface atoms with 13.3 Å and 14.9 Å for the VH versus 3.9 Å
and 13.9 Å for VL, respectively. This is likely because CDR from VH are longer on average than
those from VL. Interestingly, the seams length is divided by approximately two when considering
only interface atoms except for seam VL CDR1 – VL CDR2 where the it is divided by four.
For inter-chain contacts and considering all atoms, the length of the seam between VH CDR3
and VL CDR3 is slightly smaller than, but comparable to, those existing intra-chain seams (14.5
Å versus a median of 25.5 Å). The contacts VH CDR3 – VL CDR1 and VH CDR3 – VL CDR2
are rather unexpected and are of length of 10.0 and 5.9 Å, respectively. For interface atoms, the
length of the seam between VH CDR3 and VL CDR3 is 10.3 Å versus a median across all other
nonzero intra-chain seams of 12.6 Å.
Summarizing, the pattern of seams is the same either when considering all exposed CDR
atoms, or only interface atoms. Moreover, VH CDR3 is the one making most contacts with
other CDR, and VH CDR3 and VL CDR3 account for most of the inter-domain contacts.
Comparison between ligand types. We use the maximum normalized difference (Eq. 3)
to compare the consensus seam length and those observed for specific ligand types. When
considering seams for all the atoms, it is clearly seen that large values of MND have opposite
signs for proteins on the one hand, and peptides and chemicals on the other hand (Fig. 10), an
observation in line with the previously observed differences between ligand types. The relative
locations of the CDR are therefore different between ligand types. Intuitively, these differences
witness pre-formed features of CDR that will accommodate a particular ligand type. Moving
to seams between interface atoms only, a similar observation is also expected. This turns out
to be the case, except for the seam VH CDR3–VL CDR1, for which larger values are observed
for peptides and chemicals (Fig. 10, left). In general, VL CDR1 shows differences opposite to
VL CDR2 and VL CDR3 with respect to VH CDR3. This hints for a different role at the interface
and potentially different dynamical properties.
Comparison between V-lambda and V-kappa domain. For all atoms, the largest length
differences between V-kappa and V-lambda are found for the seams VH CDR1 – VH CDR2 (24.7
versus 20.4 Å, Supp Fig. 27), VH CDR2 – VH CDR3 (0.0 versus 3.2 Å) and VH CDR3 – VL CDR1
(9.4 versus 12.2 Å). Interestingly, two out of three are within VH and all involve VH CDR3. For
interface atoms, the largest length differences between V-kappa and V-lambda are found for the
seams VH CDR3 – VL CDR1 (5.6 versus 8.4 Å, Supp. Fig. 28), VL CDR1 – VL CDR3 (14.2
versus 11.0 Å).
The V-kappa/V-lambda classification only pertaining to the light chain, it is sound to find
differences in the relative positions of VL CDR1 and VL CDR3. Considering the differences
observed for VH CDR, one has to recall that the pairing between heavy and light chains is a
criterion during the selection of productive IG. It could be that IGLV and IGKV of light chains
have preferences for different sets of IGHV of heavy chains which would explain why looking
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at IG with kappa light chains versus lambda light chains results in structural differences in the
heavy chains.
3.4 Affinity prediction
As recalled in Introduction, estimating the affinity of an IG for an antigen is a challenging
problem, due in particular to the necessity to estimate the entropic penalty inherent to binding.
In [50], we developed an affinity estimation strategy yielding state-of-the-art results, selecting
sparse linear regressors defined from a pool of 12 variables aiming at modeling the enthalpic
and entropic changes upon binding. Of particular interest are variables coding atomic packing
properties, and the position of atoms on binding patches, using their shelling order (Fig. 1 and
[50]). To fit a model, we use the structure affinity benchmark (SAB) [34], a dataset containing
144 cases, each case being described by three crystal structures (the unbound partners and the
complex) and the experimentally measured binding affinity. Interestingly, the SAB contains 17
IG - Ag cases 1. We therefore trained the general model from [50] using the 139 − 14 cases, to
predict the affinities of the selected 14 IG - Ag cases. We note in passing that the iRMSD and
the total RMSD between the bound and unbound form of the IG are always smaller than 1.24 Å
and 0.95Å respectively. That is, the 14 cases are essentially rigid body docking cases, a property
which, however, does not warrant easiness of binding affinity prediction [50].
Upon performing the affinity prediction, our model predicts 9 (64.29 %), 13 (92.86 %) and
14 (100 %) of the Kd within one, two and three orders of magnitude respectively, with a median
absolute error of 1.024 kcal/mol (Supp. Fig. 31). From an absolute affinity prediction error,
these results are satisfactory, as predicting Kd within one order of magnitude is essentially the
best one can hope for without modeling subtle effects such as the pH in particular [31]. From
a relative standpoint, they are also informative, as an affinity enhancement of two orders of
magnitude is typically observed during affinity maturation [60].
4 Discussion
This paper presents a comprehensive analysis of IG - Ag complexes and their interfaces, based
on state-of-the-art modeling tools relying upon hierarchical Voronoi interface models and related
geometric constructions. Our dissection of IG - Ag interfaces yields a number of novel insights,
which may be summarized by considering the whole interface level and the CDR level.
Global interface statistics. While a classical focus in previous work has been the classifi-
cation of backbone conformations, an endeavor boiling down to comparing backbone traces, we
focus instead on interfacial atoms, as identified by a solvent accessible model. In doing so, one
observes that side chains contribute approximately twice as many atoms than backbones. While
this statistic stresses the need to consider all interface atoms rather than backbone ones only,
modeling side chains accurately enough to encompass their incidence on binding thermodynamic
and kinetic properties is extremely challenging, due in particular to correlations between ro-
tameric states of side-chains. The length of CDR3 also raises difficulties, and as an extreme case,
one may consider exceptionally long VH CDR3, such as thos found in bovine antibodies, where
multiple cysteines facilitate the formation of disulfide bonds and microfolds [71, 7].
1 (PDB IDs: 1AHW, 1BJ1, 1BVK, 1DQJ, 1E6J, 1FSK, 1IQD, 1JPS, 1MLC, 1NCA, 1NSN, 1P2C, 1VFB,
1WEJ, 2JEL, 2VIR and 2VIS). However, 1IQD and 1NSN are discarded as only an upper bound on their Kd is
provided in the SAB. Furthermore, 1E6J is also discarded because too many atoms could not be matched between
the bound and unbound structures.
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Additionally, the simplest and most informative variable describing protein interfaces being
the buried surface area (BSA), we refine this statistic by computing the average BSA contributed
by interfacial atoms from the IG (statistic bsaIG) and the Ag (statistic bsaAg). These quantities
turn out to be clear signatures of the ligand type, a property which can further be exploited for
classification purposes. While the classification of IG - Ag interfaces into classes depending on
structural features has already been addressed [14, 40], our parameters are the first ones yielding
such a clear separation between specific antigen types.
Contributions of CDR. In considering IG - Ag interfaces, it is generally believed that
VH CDR3 plays a prominent role [73] and is the most variable, a property owing to the ge-
netic V(D)J rearrangement mechanisms underlying its formation and that it is the one with
dominant contribution to the Ag binding. To refine this view, our goal has been to precisely
characterize the respective contributions of CDR at interfaces, and the relative positions of the
six CDR along with the ligand position across them.
For the roles of all CDRs, while we confirm the prominent role of VH CDR3, we also observe
that in terms of buried surface area, the contribution of VH CDR3 is essentially matched by the
joint contributions of VH CDR1 and VH CDR2. Thus, in terms of binding affinity and while
focusing on the interaction energy between the IG and the Ag, a precise description needs to
consider VH CDR3 and VH CDR1 + VH CDR2 on an equal footing. The BSA has long been
known as a simple and informative descriptor of interfaces [4], and we show that the average BSA
per atom is a signature of the ligand type bound by an IG. Since we also show that the length
of CDR does not correlate with their BSA, we suggests that despite the statistical significance
of correlations between CDR length and ligand type [21], predicting the ligand type bound by
an IG requires more than only CDR length information. Moreover the fact that CDR of the
same length can have radically different contribution at the interface, calls into question the
classification of CDR into canonical structures based on individual CDR lengths [54]. Finally,
we also note that VL CDR2 hardly contributes to the interface for chemical ligands, and very
little in general.
As far as the relative position of CDR is concerned, a precise characterization was missing
to complement qualitative views [20, Chapter 4]. We fill this gap analyzing seam statistics,
namely contiguous boundaries between pairs of CDR, for all CDR atoms, and also for interfacial
CDR atoms. Remarkably, out of 15 possibles seams, only seven appear, and these are remarkably
conserved–irrespective of the ligand type or the category of atoms considered. Phrased differently,
the same seams occur within VH and VL, but they are longer in VH. Several other remarkable
facts emerge from this analysis. First, the arrangement of CDR are more similar between peptide
and chemical ligands than between peptide or chemical ligands and protein ligands. In a similar
vein, the seam between VL CDR1 and VL CDR2 contributes more to the interface for protein
ligands than for peptide or chemical ligands. These features specifically identify the ligand
targeted, a property complementing the observations already made at the whole interface level.
Second, VL CDR2 is often away from the interface.
We finally note that our approach favors a purely geometric description of the IG and the
IG - Ag complex structures, and that, as such, it complements the numerous analyses focused
on CDR amino acid composition and length based on sequence data [61, 30, 26, 19] [6, 67, 5].
Affinity prediction. To complement the previous analysis, we applied recent binding affinity
predictors based on the same structural parameters [50] so as to predict the binding affinity of
14 IG with their respective Ag. These are all rigid cases as the interface RMSD and whole IG
RMSD were below 1.24 and 0.95 Å, respectively. The predictions of Kd are accurate within two
orders of magnitude for all but one complex and within one order of magnitude for 9 of them.
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Although they were obtained on a very small dataset, these results suggest that predictions at
this level of accuracy for IG may be easier than for more general protein - protein complexes
[50].
However, obtaining more accurate predictions, say within one order of magnitude or equiva-
lently within 1.4 kcal/mol remains an open problem, as taking subtle entropic effects coding the
dynamics appears mandatory [60].
Future work. This work proposes novel parameters shedding light on the specificity of IG for
their antigens, and the binding affinity of the corresponding complexes. Outstanding questions
remain, both to model interfaces of IG - Ag complexes, and to model whole IG.
At the interface level, predicting the geometry of a complex given the unbound partners, and
the associated affinity remains a daunting challenge. The classical route consists of using sampling
techniques and docking algorithms to generate poses for the complex, which are further ranked
by scoring functions aiming at detecting the most plausible ones. Our work bears promises in this
pipeline, as our structural parameters (in particular the BSA per atom and the seam patterns)
may be used to check that the complex selected matches the specific observations raised, in
particular as a function of the ligand type. Likewise, upon generating a valid geometry, our
affinity prediction tools can be used to predict the affinity–a strategy calling again for tests on
more cases. Together, these tools could lead to consequent advances in antibody design [45, 63].
At the whole IG level, various structural features of IG proteins influence their properties
whence their efficacy in the immune response. These include the ball-and-socket joint relating
VL and VH, the CL and CH1 constant domains [44, 66], and more generally the constant regions
which have been shown to influence the avidity [22, 23, 51, 57], and are involved in IG effector
properties, such as ADCC or CDC [29]. A quantitative assessment of the role of these features
requires going beyond the IG - Ag interface level, with a clear focus on the dynamics of the whole
IG protein. In doing so, novel ideas will be needed to sample efficiently conformations of whole
IG, and study the associated (potential, free) energy landscapes.
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5 Artwork
Figure 1 Voronoi interface model of an Immunoglobulin - Antigen (IG - Ag) com-
plex, defined from the solvent accessible model of the crystallographic complex. The
IG consists of H and L chains, with here the VH and VL domains shown in grey (cartoon repre-
sentation), while the Ag consists of the chain in blue (CPK representation). (Top left) IG - Ag
complex, with the six complementarity determining regions (CDR) colored using the IMGT con-
ventions (VH CDR1: red, VH CDR2: orange, VH CDR3: purple, VL CDR1: blue, VL CDR2:
green, VL CDR3: green-blue). (Top right) The Voronoi interface is a polyedral model separat-
ing the partners, whose parameters (area, curvature) convey information of the binding modes.
(Bottom left) The Voronoi interface can be divided into concentric shell. Each shell contains
the Voronoi facets which are at the same minimum distance from the interface boundary. This
distance is called the shelling order of the facet (SO for short). For instance, purple facets touch
the boundary (SO=1), blue facets must cross a purple facet to reach the boundary (SO=2),
and so on. (Bottom right) Each face of the Voronoi interface involves two interacting atoms,
either from the partners or the interfacial water molecules sandwiched between them. The buried
surface area (BSA) on each partner (by the second partner and interfacial water) is of prime in-
terest to describe the interface. For the IG, the BSA can be charged to the CDR and framework
regions (FR). (Bottom right inset) The interface atoms of a partner define its binding patch,
and, similarly to the Voronoi interface, can be shelled into concentric shells (from the outside to
the core), defining a distance to the patch boundary. The binding patch on the IG side is shown
from above (inset) to get a clearer view of all the shells.
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Figure 2 Hierarchical decomposition of the Voronoi interface of Fig. 1. The IG (or
the Fab fragment) is decomposed into heavy (H) and light (L) chains (one H and one L per
Fab) whose variable domains only (VH and VL) are of interest in this study. These domains are
further decomposed into three complementarity determining regions (CDR) and four framework
regions (FR). These fourteen primitive labels induce a partition of the Voronoi interface and
binding patches.
IG Ag
IG-Ag complex Hierarchical decomposition
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Figure 3 Average buried surface areas per atom (Equations (1) (2)): bsaIG versus
bsaAg. (Main panel) Scatter plot as a function of the ligand type. The three lines show the
separators defined by the decision tree rules, separating the ligand types (see main text and
Supp. Fig. 14). (Inset) Color gradient indicating the ligand size, in number of atoms, from
small (yellow) to large (red).
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Figure 4 Buried Surface Area (A2): relative contributions of the VH and VL.























Figure 5 Buried Surface Area (A2): relative contributions of the CDR.
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(a) Relative contributions of the CDR from VH.
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(b) Relative contributions of the CDR from VL
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Figure 6 VH CDR length versus BSA. VH CDR1 and VH CDR2 are grouped due to their
common genomic origin.
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(a) VH CDR1 and VH CDR2, Human. Five com-
plexes are discarded because of aberrant VH CDR1
and VH CDR2 lengths (see Supp. Section 6.2).
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(b) VH CDR1 and VH CDR2, Mouse.




















(c) VH CDR3, Human. Twelve complexes are dis-
carded because of aberrant VL CDR1 and VL CDR2
lengths (see Supp. Section 6.2).
























(d) VH CDR3, Mouse.
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Figure 7 VL CDR length versus BSA. VL CDR1 and VL CDR2 are grouped due to their
common genomic origin.
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(a) VL CDR1 and VL CDR2, Human. The
[CDR1.CDR2] lengths [6.3] characterize both V-
kappa and V-lambda. The other lengths charac-
terize either V-kappa ([7.3], [11.3] and [12.3]) or V-
lambda ([8.3] and [9.3]).
0 50 100 150 200 250 300 350 400

































(b) VL CDR1 and VL CDR2, Mouse. The
[CDR1.CDR2] lengths [7.7] and [9.3] characterize V-
lambda. The other lengths characterize V-kappa.
























(c) VL CDR3, Human.





















(d) VL CDR3, Mouse.
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Figure 8 Relative position of CDR analyzed with seams statistics. Heavy chain (chain
B) from 1A2Y, with CDR shown using the IMGT color scheme, namely red: CDR1, orange:
CDR2, purple: CDR3. The seam between two CDR is the the curve separating their exposed
atoms in their solvent accessible representations. It consists of circle arcs contributed by pairs
of intersecting atoms. On this example, the seam between VH CDR1 and VH CDR2 involves 11




Figure 9 Consensus representations for seams between CDR. The contacts between the
6 CDR are represented as a graph, with one edge between two CDR for which seam statistics
were collected. The statistic reported is the median value of all the observations (in Å). Dashed
edges show inter-chain contacts. See section 6.3 for equivalent figures as a function of the ligand



























All atoms Interface atoms
RR n° 8770
22 Marillet and Cazals
Figure 10 Comparison between the consensus median seam lengths and the median
lengths for specific ligand types. The y axis represents the maximum normalized difference
(Eq. (3)) between the consensus median length and the median length for specific ligand types.
Filled bars correspond to inter-chain contacts. Note that for a given ligand type, there are 7 bars
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6 Supplemental: Results
6.1 Dataset
We use the IMGT/3Dstructure-DB database [25], version of January 2015. For each entry, the
atoms of the complementarity determining regions (CDR) of the IG are annotated using the
IMGT unique numbering scheme [43], recalled in Table 1. Out of 1363 submitted files, 1035 were
processed (other were discarded because of various problems, see the report in appendix), 596
complexes were extracted after the redundancy was filtered, out of which 537 could be part of
the analysis (26 other were discarded because there was no interface or the contacts were not
made with the Fab of the IG)
Table 1 Amino acid positions associated with each IMGT label defining the decom-
position of a V-domain into seven regions Positions of the complementarity determining
regions (CDR) using the IMGT numbering scheme [43].
Region FR1 CDR1 FR2 CDR2 FR3 CDR3 FR4
start-stop 1 - 26 27 - 38 39 - 55 56 - 65 66 - 104 105 - 117 118 - 128
Table 2 Summary of the number of IG - Ag complexes in each class of species / ligand
type. The dataset includes VH (V-domains of heavy chains)and VL comprising
V-KAPPA (V domains of kappa chains) and V-LAMBDA (V domains of lambda
chains.
Mouse Human Other total
Peptide 81 34 11 126
Protein 191 104 31 326
Chemical 65 7 5 77
total 337 145 47 529
Table 3 Number of occurrences of the isotypes in the dataset
Isotype A G M Unknown
Number of occurrences 1 484 0 44
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Table 4 V-domains of the IG – Ag complexes are assigned to the respective sub-
groups: VH to the IGHV subgroups, V-kappa to the IGKV subgroups and V-lambda
to the IGLV subgroups. The number (Nb) of functional (F) genes per IGHV, IGKV and IGLV
subgroup in human (Homo sapiens) and the CDR1 and CDR2 lengths [CDR1.CDR2.] of the
germline genes are from IMGT Protein displays. Eight complexes were annotated with aberrant
CDR lengths considering their IGH subgroup, twelve considering their IGK subgroups, and one
considering its IGL subgroup. They were not counted in this table.
Human
IGHV subgroups and genes IGKV subgroups and genes IGLV subgroups and genes
Subgroup [CDR1.CDR2] NB F VH Subgroup
[CDR1.
CDR2] NB F V-kappa Subgroup
[CDR1.
CDR2] NB F V-lambda
IGHV1 [8.8] 11 36 IGKV1 [6.3] 19 58 IGLV1 [8.3] 4 27
[9.3] 1 0
IGHV2 [10.7] 3 3 IGKV2 [11.3] 7 3 IGLV2 [9.3] 5 3
[12.3] 2 0
IGHV3 [8.8] 16 60 IGKV3 [6.3] 4 8 IGLV3 [6.3] 10 13
[8.7] 3 2 [7.3] 3 14
[8.10] 4 5
IGHV4 [9.7] 3 2 IGKV4 [12.3] 1 3 IGLV4 [7.7] 3 0
[8.7] 2 10
[10.7] 5 2
IGHV5 [8.8] 2 12 IGKV5 [6.3] 1 0 IGLV5 [9.7] 4 0
IGHV6 [10.9] 1 2 IGKV6 [6.3] 2 0 IGLV6 [8.3] 1 2
IGHV7 [8.8] 1 3 IGLV7 [9.3] 2 1
IGLV8 [9.3] 1 0
IGLV9 [7.8] 1 0
IGLV10 [8.3] 1 0
Total 137 86 46
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Table 5 V-domains of the IG – Ag complexes are assigned to the respective sub-
groups: VH to the IGHV subgroups, V-kappa to the IGKV subgroups and V-lambda
to the IGLV subgroups. The number (Nb) of functional (F) genes per IGHV, IGKV and IGLV
subgroup in mouse (Mus musculus) and the CDR1 and CDR2 lengths [CDR1.CDR2.] of the
germline genes are from IMGT Protein displays. One complex was annotated with aberrant
CDR lengths considering its IGK subgroup and was therefore not counted in this table.
Mouse
IGHV subgroups and genes IGKV subgroups and genes IGLV subgroups and genes
Subgroup [CDR1.CDR2] NB F VH Subgroup
[CDR1.
CDR2] NB F V-kappa Subgroup
[CDR1.
CDR2] NB F V-lambda
IGHV1 [8.8] 111 121 IGKV1 [11.3] 8 63 IGLV1 [9.3] 2 22
IGHV2 [8.7] 22 16 IGKV2 [11.3] 4 10 IGLV2 [7.7] 1 2
IGHV3 [10.7] 2 0 IGKV3 [10.3] 10 28
[9.7] 3 26
[8.7] 3 8
IGHV4 [8.8] 1 18 IGKV4 [7.3] 11 15
[5.3] 14 36
IGHV5 [8.8] 26 40 IGKV5 [6.3] 12 25
[8.7] 1 6
IGHV6 [8.10] 5 11 IGKV6 [6.3] 12 14
IGHV7 [8.10] 3 20 IGKV7 [12.3] 1 0
IGHV8 [10.7] 6 20 IGKV8 [12.3] 8 33
IGHV9 [8.8] 8 24 IGKV9 [6.3] 3 5
IGHV10 [8.10] 4 6 IGKV10 [6.3] 3 29
IGHV11 [8.8] 2 0 IGKV11 [6.3] 1 1
IGHV12 [10.7] 1 1 IGKV12 [6.3] 7 18
[9.7] 1 0
IGHV13 [8.10] 1 0 IGKV13 [6.3] 2 6
IGHV14 [8.8] 5 20 IGKV14 [6.3] 4 19
IGHV15 [9.8] 1 0 IGKV15 [6.3] 0 0
IGHV16 [9.8] 1 0 IGKV16 [6.3] 1 4
IGKV17 [6.3] 2 3
IGKV18 [6.3] 1 0
IGKV19 [6.3] 1 3
IGKV20 [6.3] 1 0
Total 337 312 24
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Figure 11 Size of antigens (number of atoms) Two large peptides (IMGT-PDB file 3W11
chain E, 2301 atoms, and IMGT-PDB file 4R4N chain I, 5172 atoms) are not displayed for
readability.







25Ag size distribution for Chemical (77 structures)










160Ag size distribution for Protein (326 structures)











45Ag size distribution for Peptide (124 structures)
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Figure 12 Distribution of the resolution of structures
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Figure 13 Buried Surface Area versus number of atoms: whole interface, IG side,
Ag side. The strong correlation between BSAand |I| (panel (a)) gets weaker when considering
the IG (panel (b)) and the Ag sides (panel (c)) separately.

























(a) one BSA versus |I|.

























(b) BSAIG versus |IIG|.


























(c) BSAAg versus |IAg|.
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Table 7 Confusion matrix for ligand type prediction. Results when the tree is run as a
classifier on the training data, for the pruned decision tree using variables bsaAg and bsaIG.
XXXXXXXXXXPredicted
Actual Chemical Peptide Protein
Chemical 75 3 1
Peptide 2 104 16
Protein 0 19 309
Figure 14 Rules characterizing the binding patch depending on the ligand types.
See main text for details. The classification rules are: bsaAg ≥ 14.32: chemical ligand; 10.76 ≤
bsaAg < 14.32: peptide ligand; bsaAg < 10.76 AND bsaIG < 5.697: peptide ligand; bsaAg < 10.76
AND bsaIG ≥ 5.697: protein ligand.
Chemical Peptide Peptide Protein
bsaI G < 5.697
bsaA g >= 10.76
< 10.76
< 14.32 >= 5.697
bsaA g >= 14.32
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Figure 15 Fraction of interface atoms contributed by the side-chains of the amino
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6.2 Lengths of CDR
We now study the distribution of CDR lengths in our dataset. The IG - Ag complexes found in
our dataset represent well the whole of existing subgroups, both for human and mice, in terms
of [CDR1.CDR2] lengths (Supp. Tables 4 and 5).
Supp. Fig. 16 displays the abundance of combinations of CDR1/CDR2 and CDR3 lengths
for VH and VL in the mouse and human. CDR1 and CDR2 are grouped in pairs because they
share the same genomic origin whereas CDR3 is the product of an entirely different process [20,
Chapter 6]. We now discuss in order: VH CDR and VL CDR of human IG, and VH CDR and
VL CDR of murine IG.
Notice that when discussing the lengths of VH CDR, the human dataset consists of 140
complexes instead of 145 because we discard 5 complexes whose VH CDR1 andVH CDR2 lengths
are aberrant (annotation not corresponding to any existing V-gene). For the same reason, we
consider 133 complexes for VL CDR in the human dataset after discarding 12 of them for aberrant
VH CDR1 and VH CDR2 lengths.
For VH CDR in human, a striking 81% (113/140) of IG have both their VH CDR1 and
VH CDR2 of length 8 although 6 different pairs occur. Except for a peak at 12 amino acids
(15% of the dataset, 21/140), the lengths for 94% (132/140) of VH CDR3 are evenly distributed
between 10 and 22 amino acids; even though it can reach a minimum of 6 and a maximum of 25
amino acids.
For VL CDR in the human, 59% (79/133) of IG have their VL CDR1 and VL CDR2 of length
6 an 3, respectively; for 22% (29/133) they are of length 8 and 3; and for 10% (14/133) they
are of length 7 and 3. Those three pairs therefore make up 92% of the human IG in this dataset
although 6 distinct pairs actually occur. Interestingly, only VL CDR2 consisting of two amino
acids occur in the dataset. VL CDR3 is made of 9 amino acids in 56% (75/133) of the IG and
of 10, 11 and 12 amino acids in 11% (15/133), 13% (18/133) and 7% (10/133) of the human IG.
This makes 89% of all human IG in our dataset even though 9 distinct length actually occur.
Interestingly, 35% (46/133) of the human IG have CDR of lengths 6, 3, and 9 for VL CDR1,
VL CDR2 and VL CDR3, respectively. Moreover, the 5 combinations out of 26 ([6.3.9], [8.3.9],
[6.3.10], [7.3.9], [6.3.11]) make 65% of the dataset.
From this analysis, it stems that:
• for human IG, the major locus of diversity is VH CDR3,
• whichever V gene is encoding the V-region, VL CDR2 is always of length 3,
• a single combination of VL CDR represents more than a third of the human dataset.
For VH CDR in mice, the situation is similar to that of human IG for VH CDR1 and
VH CDR2: both are of length 8 for 66% (223/337) of the dataset although 5 distinct pairs occur.
As for human IG, the most represented length for VH CDR3 is 12 (19% of the dataset, 65/337).
Additionally, 71% (239/337) of murine VH CDR3 have between 11 and 15 amino acids while the
minimum and maximum lengths are 5 and 20, respectively.
For VL CDR in the mouse, 38% (127/337) of IG have their VL CDR1 and VL CDR2 of
length 6 and 3, respectively. Additionally, they are of length 11 and 3 for 22% (73/337) of the
dataset. A longer VL CDR1 is therefore more common in mice than in humans. Similarly to
the human dataset, only two IG have a VL CDR2 of length other than 3 (namely 7). The
overwhelming majority (86%, 290/337) of murine IG have a VL CDR3 of length 9 although
four distinct lengths occur. Finally, two particular combinations of CDR are over-represented:
[6.3.9] and [11.3.9] for [VL CDR1.VL CDR2.VL CDR3 ] which occur for 35% (119/337) and 19%
(65/337) of the murine IG, respectively.
RR n° 8770
38 Marillet and Cazals
The two first points of the discussion for human IG also hold for murine IG. Moreover, two
combinations of VL CDR make up half of the dataset. Finally we notice that VL CDR1 is more
variable in length than VL CDR3.
Figure 16 Length of the CDR in number of amino acids. The four panels correspond to
the combinations {VH, VL } × {Human, Mouse}. For a given matrix, the gray shade encodes
the number of occurrences found in the dataset, from white (null count) to black (maximum for
that matrix, as indicated on the vertical bar on the right hand side.)
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(a) VH, Human. Five complexes are discarded be-
cause of aberrant VH CDR1 and VH CDR2 lengths.
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(c) VL, Human. Twelve complexes are discarded be-
cause of aberrant VL CDR1 and VL CDR2 lengths.
The [CDR1.CDR2] lengths [6.3] characterize both
V-kappa and V-lambda. The other lengths char-
acterize either V-kappa ([7.3], [11.3] and [12.3]) or
V-lambda ([8.3] and [9.3]).
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Counts of the various combinations 



























(d) VL, Mouse. The [CDR1.CDR2] lengths [7.7]
and [9.3] characterize V-lambda. The other lengths
characterize V-kappa.
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6.3 Seams between CDR
In this section, we present seam statistics, for all ligands, and then for ligands of a given type.
As opposed to Fig. 19, all figures were generated automatically. Thus, for the sake of uniformity,
Fig. 9 reproduces the lengths displayed on Fig. 19.
Figure 19 Length of the seams between CDR for all atoms (whole dataset). The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the






























VH CDR1 - VH CDR2 24.6 24.4
VH CDR1 - VH CDR3 30.9 31.8
VH CDR1 - VL CDR3 0.0 0.8
VH CDR2 - VH CDR3 0.0 5.3
VH CDR2 - VL CDR1 0.0 0.0
VH CDR2 - VL CDR3 0.0 1.3
VH CDR3 - VL CDR1 10.0 10.1
VH CDR3 - VL CDR2 5.9 6.4
VH CDR3 - VL CDR3 14.5 15.2
VL CDR1 - VL CDR2 16.0 16.2
VL CDR1 - VL CDR3 26.9 26.1
VL CDR2 - VL CDR3 0.0 0.7
Figure 20 Length of the seams between CDR for interface atoms (whole dataset).
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the






























VH CDR1 - VH CDR2 13.3 13.4
VH CDR1 - VH CDR3 14.9 15.3
VH CDR1 - VL CDR3 0.0 0.7
VH CDR2 - VH CDR3 0.0 3.9
VH CDR2 - VL CDR3 0.0 1.0
VH CDR3 - VL CDR1 6.0 6.4
VH CDR3 - VL CDR2 0.8 3.0
VH CDR3 - VL CDR3 10.3 10.4
VL CDR1 - VL CDR2 3.9 5.3
VL CDR1 - VL CDR3 13.9 12.7
VL CDR2 - VL CDR3 0.0 0.5
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Figure 21 Length of the seams between CDR for protein ligands, all atoms. The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the
































VH CDR1 - VH CDR2 24.2 24.1
VH CDR1 - VH CDR3 31.0 31.9
VH CDR1 - VL CDR3 0.0 0.5
VH CDR2 - VH CDR3 0.0 6.1
VH CDR2 - VL CDR3 0.0 1.3
VH CDR3 - VL CDR1 9.2 9.3
VH CDR3 - VL CDR2 6.3 6.5
VH CDR3 - VL CDR3 16.8 16.9
VL CDR1 - VL CDR2 14.8 15.3
VL CDR1 - VL CDR3 24.9 24.9
VL CDR2 - VL CDR3 0.0 0.9
Figure 22 Length of the seams between CDR for protein ligands, interface atoms.
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the































VH CDR1 - VH CDR2 14.9 15.2
VH CDR1 - VH CDR3 16.1 16.9
VH CDR1 - VL CDR3 0.0 0.5
VH CDR2 - VH CDR3 0.0 4.5
VH CDR2 - VL CDR3 0.0 1.0
VH CDR3 - VL CDR1 5.5 5.8
VH CDR3 - VL CDR2 2.3 3.8
VH CDR3 - VL CDR3 10.9 10.9
VL CDR1 - VL CDR2 5.7 6.3
VL CDR1 - VL CDR3 14.0 13.0
VL CDR2 - VL CDR3 0.0 0.6
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Figure 23 Length of the seams between CDR for peptide ligands, all atoms. The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the
































VH CDR1 - VH CDR2 24.6 24.4
VH CDR1 - VH CDR3 27.8 30.3
VH CDR1 - VL CDR3 0.0 0.8
VH CDR2 - VH CDR3 0.0 3.6
VH CDR2 - VL CDR3 0.0 1.0
VH CDR3 - VL CDR1 10.6 11.0
VH CDR3 - VL CDR2 5.8 6.4
VH CDR3 - VL CDR3 11.8 12.7
VL CDR1 - VL CDR2 18.3 17.8
VL CDR1 - VL CDR3 28.7 28.1
VL CDR2 - VL CDR3 0.0 0.4
Figure 24 Length of the seams between CDR for peptide ligands, interface atoms.
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the






























VH CDR1 - VH CDR2 11.9 12.7
VH CDR1 - VH CDR3 15.0 14.3
VH CDR1 - VL CDR3 0.0 0.8
VH CDR2 - VH CDR3 0.0 3.0
VH CDR2 - VL CDR3 0.0 0.7
VH CDR3 - VL CDR1 8.2 7.9
VH CDR3 - VL CDR2 0.1 2.3
VH CDR3 - VL CDR3 9.7 9.9
VL CDR1 - VL CDR2 3.3 4.8
VL CDR1 - VL CDR3 14.7 14.5
VL CDR2 - VL CDR3 0.0 0.3
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Figure 25 Length of the seams between CDR for chemical ligands, all atoms. The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the































VH CDR1 - VH CDR2 26.1 25.8
VH CDR1 - VH CDR3 33.1 33.8
VH CDR1 - VL CDR3 0.0 2.0
VH CDR2 - VH CDR3 0.0 5.0
VH CDR2 - VL CDR1 0.0 0.1
VH CDR2 - VL CDR3 0.0 1.7
VH CDR3 - VL CDR1 12.8 12.2
VH CDR3 - VL CDR2 5.2 6.1
VH CDR3 - VL CDR3 11.9 12.1
VL CDR1 - VL CDR2 17.8 17.1
VL CDR1 - VL CDR3 28.1 28.3
VL CDR2 - VL CDR3 0.0 0.4
Figure 26 Length of the seams between CDR for chemical ligands, interface atoms.
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the























VH CDR1 - VH CDR2 6.5 7.1
VH CDR1 - VH CDR3 9.8 10.3
VH CDR1 - VL CDR3 0.0 1.8
VH CDR2 - VH CDR3 0.0 2.6
VH CDR2 - VL CDR3 0.0 1.3
VH CDR3 - VL CDR1 6.5 6.6
VH CDR3 - VL CDR2 0.0 1.0
VH CDR3 - VL CDR3 8.9 9.5
VL CDR1 - VL CDR2 0.0 1.5
VL CDR1 - VL CDR3 8.7 9.0
VL CDR2 - VL CDR3 0.0 0.3
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Figure 27 Length of the seams between CDR for VL = V-kappa, all atoms. The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the





























VH CDR1 - VH CDR2 24.7 24.7
VH CDR1 - VH CDR3 31.0 31.8
VH CDR1 - VL CDR3 0.0 0.8
VH CDR2 - VH CDR3 0.0 5.1
VH CDR2 - VL CDR1 0.0 0.0
VH CDR2 - VL CDR3 0.0 1.2
VH CDR3 - VL CDR1 9.4 9.6
VH CDR3 - VL CDR2 6.1 6.4
VH CDR3 - VL CDR3 14.9 15.3
VL CDR1 - VL CDR2 16.3 16.4
VL CDR1 - VL CDR3 26.5 25.8
VL CDR2 - VL CDR3 0.0 0.8
Figure 28 Length of the seams between CDR for VL = V-kappa, interface atoms.
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the






























VH CDR1 - VH CDR2 13.3 13.5
VH CDR1 - VH CDR3 14.8 15.1
VH CDR1 - VL CDR3 0.0 0.7
VH CDR2 - VH CDR3 0.0 3.8
VH CDR2 - VL CDR3 0.0 0.9
VH CDR3 - VL CDR1 5.6 6.2
VH CDR3 - VL CDR2 0.7 3.0
VH CDR3 - VL CDR3 10.4 10.7
VL CDR1 - VL CDR2 3.6 5.0
VL CDR1 - VL CDR3 14.2 13.0
VL CDR2 - VL CDR3 0.0 0.6
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Figure 29 Length of the seams between CDR for VL = V-lambda, all atoms. The
contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the

































VH CDR1 - VH CDR2 20.4 22.9
VH CDR1 - VH CDR3 29.9 31.8
VH CDR1 - VL CDR3 0.0 1.0
VH CDR2 - VH CDR3 3.2 6.5
VH CDR2 - VL CDR3 0.0 1.8
VH CDR3 - VL CDR1 12.2 13.0
VH CDR3 - VL CDR2 3.8 6.6
VH CDR3 - VL CDR3 12.6 14.5
VL CDR1 - VL CDR2 14.0 14.9
VL CDR1 - VL CDR3 28.2 28.4
Figure 30 Length of the seams between CDR for VL = V-lambda, interface atoms.
The contacts between the 6 CDR are represented as a graph, with one edge between two CDR
for which seam statistics were collected. The statistic reported is the median value of all the































VH CDR1 - VH CDR2 13.4 13.2
VH CDR1 - VH CDR3 15.3 16.3
VH CDR1 - VL CDR3 0.0 0.9
VH CDR2 - VH CDR3 0.0 4.3
VH CDR2 - VL CDR3 0.0 1.1
VH CDR3 - VL CDR1 8.4 8.0
VH CDR3 - VL CDR2 0.9 3.2
VH CDR3 - VL CDR3 9.0 9.0
VL CDR1 - VL CDR2 5.3 6.8
VL CDR1 - VL CDR3 11.0 10.9
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Figure 31 Predicted versus experimental affinities for IG - Ag complexes. Dashed,
dash-dotted and dotted lines respectively show errors of±1.4, ±2.8, ±4.2 kcal/mol, corresponding






































Figure 32 Distribution of the length of the seams between CDR. Comparison between
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Figure 33 Distribution of the length of the seams between CDR. Comparison between









































































































































































































































































































































































































































































r Peptide (126 structures)
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Figure 34 Distribution of the length of the seams between CDR. Comparison between







































































































































































































































































































































































































































































r Human (145 structures)
Figure 35 Distribution of the length of the seams between CDR. Comparison between
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Figure 36 Distribution of the length of the seams between CDR. Comparison between











































































































































































































































































































































































































































































r Peptide (126 structures)
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r Human (145 structures)
Correlation between seam length and interface curvature / ligand size. We investi-
gated the correlation between individual seams lengths and three parameters: the size of the Ag
and the curvature of the interface on both the IG and Ag side (Supp. Tables 8-13).
Note that the values in Supp. Tables 8 are the opposite of those in Supp. Tables 10. The
same applies for Supp. Tables 9 and 11. This is expected since the curvatures of both size of the
interface are complementary. We therefore limit our discussion to Supp. Tables 8, 9, 12 and 13.
Overall, the correlation are low, ranging from -0.37 to 0.21 for linear relationships and from
-0.36 to 0.31 for non-linear monotonous relationships.
Considering the seams between all atoms, linear correlations range between -0.37 (VH CDR3-
VL CDR3 versus interface curvature) and 0.21 (VH CDR3- VL CDR3 versus Ag size) and
non-linear monotonous correlations range between -0.36 (VH CDR3- VL CDR3 versus interface
curvature) and 0.31 (VH CDR3- VL CDR3 versus interface Ag size).
Considering the seams between interface atoms, linear correlations range between -0.22 (VH CDR1-
VH CDR3 versus interface curvature) and 0.19 (VH CDR1- VL CDR3 vs interface curvature and
VH CDR1- VH CDR3 versus Ag size), and non-linear monotonous correlations range between
-0.23 (VH CDR1- VL CDR3 vs Ag size) and 0.29 (VH CDR1- VH CDR3 versus interface Ag
size).
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Table 8 Correlation between length of seams at interface and curvature of the in-
terface, IG side
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson -0.11 -0.22 - - 0.19
p-value 8.236e-03 4.548e-07 - - 8.130e-06
Spearman -0.12 -0.20 - - 0.18
p-value 7.876e-03 2.777e-06 - - 3.107e-05
VH CDR2
Pearson - -0.20 - - -0.05
p-value - 5.416e-06 - - 2.711e-01
Spearman - -0.22 - - -0.04
p-value - 3.852e-07 - - 3.135e-01
VH CDR3
Pearson - - 0.01 -0.15 0.06
p-value - - 7.612e-01 5.687e-04 1.876e-01
Spearman - - -0.02 -0.17 0.02
p-value - - 7.017e-01 1.060e-04 5.906e-01
VL CDR1
Pearson - - - -0.17 0.07
p-value - - - 1.108e-04 1.259e-01
Spearman - - - -0.18 0.07
p-value - - - 2.516e-05 1.264e-01
VL CDR2
Pearson - - - - -0.02
p-value - - - - 6.953e-01
Spearman - - - - -0.01
p-value - - - - 8.840e-01
Table 9 Correlation between length of seams and curvature of the interface, IG side
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson 0.16 -0.08 - - 0.18
p-value 1.679e-04 7.329e-02 - - 4.345e-05
Spearman 0.15 -0.04 - - 0.14
p-value 5.268e-04 3.527e-01 - - 1.399e-03
VH CDR2
Pearson - -0.22 0.03 - -0.07
p-value - 3.833e-07 4.445e-01 - 9.498e-02
Spearman - -0.23 0.04 - -0.07
p-value - 1.160e-07 3.843e-01 - 1.171e-01
VH CDR3
Pearson - - -0.00 -0.05 -0.37
p-value - - 9.254e-01 2.514e-01 3.028e-18
Spearman - - -0.02 -0.07 -0.36
p-value - - 7.084e-01 1.225e-01 2.819e-17
VL CDR1
Pearson - - - 0.17 0.17
p-value - - - 5.701e-05 6.837e-05
Spearman - - - 0.19 0.21
p-value - - - 1.242e-05 7.123e-07
VL CDR2
Pearson - - - - -0.06
p-value - - - - 1.439e-01
Spearman - - - - -0.06
p-value - - - - 2.063e-01
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Table 10 Correlation between length of seams at interface and curvature of the
interface, Ag side
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson 0.11 0.22 - - -0.19
p-value 8.236e-03 4.548e-07 - - 8.130e-06
Spearman 0.12 0.20 - - -0.18
p-value 7.876e-03 2.777e-06 - - 3.107e-05
VH CDR2
Pearson - 0.20 - - 0.05
p-value - 5.416e-06 - - 2.711e-01
Spearman - 0.22 - - 0.04
p-value - 3.852e-07 - - 3.135e-01
VH CDR3
Pearson - - -0.01 0.15 -0.06
p-value - - 7.612e-01 5.687e-04 1.876e-01
Spearman - - 0.02 0.17 -0.02
p-value - - 7.017e-01 1.060e-04 5.906e-01
VL CDR1
Pearson - - - 0.17 -0.07
p-value - - - 1.108e-04 1.259e-01
Spearman - - - 0.18 -0.07
p-value - - - 2.516e-05 1.264e-01
VL CDR2
Pearson - - - - 0.02
p-value - - - - 6.953e-01
Spearman - - - - 0.01
p-value - - - - 8.840e-01
Table 11 Correlation between length of seams and curvature of the interface, Ag
side
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson -0.16 0.08 - - -0.18
p-value 1.679e-04 7.329e-02 - - 4.345e-05
Spearman -0.15 0.04 - - -0.14
p-value 5.268e-04 3.527e-01 - - 1.399e-03
VH CDR2
Pearson - 0.22 -0.03 - 0.07
p-value - 3.833e-07 4.445e-01 - 9.498e-02
Spearman - 0.23 -0.04 - 0.07
p-value - 1.160e-07 3.843e-01 - 1.171e-01
VH CDR3
Pearson - - 0.00 0.05 0.37
p-value - - 9.254e-01 2.514e-01 3.028e-18
Spearman - - 0.02 0.07 0.36
p-value - - 7.084e-01 1.225e-01 2.819e-17
VL CDR1
Pearson - - - -0.17 -0.17
p-value - - - 5.701e-05 6.837e-05
Spearman - - - -0.19 -0.21
p-value - - - 1.242e-05 7.123e-07
VL CDR2
Pearson - - - - 0.06
p-value - - - - 1.439e-01
Spearman - - - - 0.06
p-value - - - - 2.063e-01
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Table 12 Correlation between length of seams at interface and Ag size
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson 0.06 0.19 - - -0.15
p-value 1.730e-01 1.285e-05 - - 4.892e-04
Spearman 0.23 0.29 - - -0.23
p-value 7.413e-08 1.448e-11 - - 9.712e-08
VH CDR2
Pearson - 0.11 - - 0.00
p-value - 1.447e-02 - - 9.462e-01
Spearman - 0.13 - - -0.04
p-value - 2.323e-03 - - 4.214e-01
VH CDR3
Pearson - - -0.00 0.04 0.08
p-value - - 9.493e-01 3.680e-01 5.721e-02
Spearman - - -0.03 0.21 0.13
p-value - - 5.235e-01 9.478e-07 2.135e-03
VL CDR1
Pearson - - - 0.13 -0.17
p-value - - - 2.646e-03 8.668e-05
Spearman - - - 0.22 -0.05
p-value - - - 5.204e-07 2.238e-01
VL CDR2
Pearson - - - - 0.01
p-value - - - - 7.755e-01
Spearman - - - - 0.09
p-value - - - - 3.920e-02
Table 13 Correlation between length of seams and Ag size
VH CDR2 VH CDR3 VL CDR1 VL CDR2 VL CDR3
VH CDR1
Pearson -0.11 0.14 - - -0.13
p-value 1.532e-02 1.373e-03 - - 1.910e-03
Spearman -0.12 0.06 - - -0.19
p-value 6.057e-03 1.838e-01 - - 1.204e-05
VH CDR2
Pearson - 0.11 -0.03 - -0.00
p-value - 1.554e-02 4.884e-01 - 9.146e-01
Spearman - 0.08 -0.07 - -0.03
p-value - 5.079e-02 1.192e-01 - 5.038e-01
VH CDR3
Pearson - - 0.09 -0.08 0.21
p-value - - 4.017e-02 7.548e-02 6.631e-07
Spearman - - -0.02 0.00 0.31
p-value - - 7.262e-01 9.625e-01 1.407e-13
VL CDR1
Pearson - - - -0.18 -0.26
p-value - - - 2.731e-05 2.120e-09
Spearman - - - -0.24 -0.29
p-value - - - 2.542e-08 7.610e-12
VL CDR2
Pearson - - - - 0.01
p-value - - - - 8.804e-01
Spearman - - - - 0.11
p-value - - - - 1.410e-02
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These values are too low to bring about any meaningful conclusions, but we notice that 1) the
previous highest correlations only involve VH CDR3- VL CDR3 or seams between VH CDR1 and
the CDR3 from both VH and VL; 2) the seams VH CDR3- VL CDR3 and VH CDR1- VH CDR3
show the highest absolute linear correlations with both interface curvature and Ag size for all
atoms and interface atoms respectively.
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7 Supplemental: Dataset Curation
7.1 Inferring Canonical Complexes
A canonical configuration for a IMGT/3Dstructure-DB IMGT-PDB file is as follows: one H
chain, one L chain, one ligand. A non canonical configuration may occur for different reasons:
• The asymmetric unit of the crystal structure contains two or more Fabs.
• Several molecules have co-cristallized with the IG - Ag complex.
• Two IG chains, H and L, and one Ag chain are found but the IG chains are not annotated
as forming a receptor in the IMGT 410 section.
• An IG receptor is annotated as containing more than two chains.
• The ligand is a multi-chain protein
The following issues are faced:
• A file may not be canonical i.e. there might be several complexes in a single file.
• There might be some issues with the numbering of the chains.
• There might be missing data (residues, chains information, labels)
• Several complexes might be similar and bias the results.
• Some molecules annotated as ligand may actually be buffer molecules (e.g. glycerol)
• Some purification proteins remain (e.g. protein L, A or G) and do not engage in specific
contacts with the IG
Using the Voronoi interface model presented in section 2.1, we proceed in two steps. First,
we infer the chains pairings in every file which does not contain a canonical complex. For this,
we compute the interfaces between all pairs of chains. We then group L and H chains in pairs for
which the number of atoms at the interface is the highest. We then assign the ligand(s) chains
to the HL pairs if they make contacts with either chain.
Note that in the case where an Ag is in contact with several IG, it will be assigned to both
IG.
Finally, all buffer molecules and IG purification proteins (namely protein L, A and G whose
annotated name satisfy the regexp "immunoglobulin g-binding|protein[ ]+[gl]($|\s|\’)|glycerol"
are removed from the files because they are not representative of IG - Ag interactions.
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Figure 38 Inferring complexes within an IMGT-PDB file (IMGT-1GGI.pdb): crystal
structure in its van der Waals representation, and associated connectivity graph
from which two complexes are defined. (Left) The seven chains from the file: L (blue), H
(red), P (grey), J (yellow), M (orange), Q (chartreuse green). (Right) The graph summarizes
the connectivity between chains computed by intervor-bif, from the package Intervor. Vertices
are chains (with their IDs) and the edges are weighted by the number of atoms at the interface.
Here H and J are the Fab heavy chains, L and M are the Fab light chains and P and Q are the













Crystal contacts. The previous automatic detection raises the problem of crystal contacts,
since complexes reported might be false positives.
They could potentially be ruled out by using a cutoff such as the minimal number of atoms
at an interface to be considered significant, however, there might also be few contacts between
a Fab and a small ligand. It is therefore necessary to study the distribution of the number of
atoms at the interface for different classes of ligands to set a specific cutoff.
To circumvent this issue, we currently exclude from the analysis complexes which do not have
at least one contact with the variable domain (CDR or FR).
7.2 Removing redundancies
Redundant complexes may come from two sources: the same complex may be found in the same
asymmetric crystal unit, or it may be found in two different IMGT-PDB files.
We therefore need to remove the redundancy of the dataset to avoid biasing the statistics.
For this, we need to consider similarities at the interface level. Once all complexes are extracted
from the database, we need to compare the interfaces of all pairs of complexes, group complexes
having a similar interface, and keep one representative complex for each group.
Currently, we rely on a quick method based upon IMGT labels. We consider triplets formed
by the IMGT labels of both IG chains and the Ag chain. We record triplets which have already
been included in the analysis and exclude complexes which make the same triplet.
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